Search Results

Add or switch to systemics and biologics where topical paediatric hidradenitis suppurativa therapy fails.

• Authors : Fenton, Caroline; Kang, Connie

Subjects: ANTIBIOTICS; BIOTHERAPY; CUTANEOUS therapeutics

• Source: Drugs & Therapy Perspectives; Jun2024, Vol. 40 Issue 6, p211-215, 5p

Record details

Health Canada approves Cosentyx[R], a biologic therapy, for the treatment of adults with moderate to severe Hidradenitis Suppurativa (HS).

• Source: CNW Group. 2024.

Record details

[Letter to the Editor - "Guidelines for Management of Patients with Hidradenitis Suppurativa": The Importance of Collaboration with Infectious Diseases].

• Authors : Matos J; Serviço de Doenças Infeciosas. Centro Hospitalar Universitário de Santo António. Porto. Portugal.; Furtado I

Subjects: Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/diagnosis ; Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/therapy ; Communicable Diseases*/Communicable Diseases*/Communicable Diseases*/complications

• Source: Acta medica portuguesa [Acta Med Port] 2024 Mar 01; Vol. 37 (3), pp. 231-232. Date of Electronic Publication: 2024 Mar 01.Publisher: Centro Editor Livreiro da Ordem dos Médicos Country of Publication: Portugal NLM ID: 7906803 Publication Model: Print-Electronic Cited Medium:

Record details

Carta ao Editor – “Recomendações na Abordagem do Doente com Hidradenite Supurativa”: A Importância da Colaboração com Doenças Infeciosas.

• Authors : MATOS, João; FURTADO, Isabel; TORRES, Tiago

• Source: Acta Médica Portuguesa; Mar2024, Vol. 37 Issue 3, p231-232, 2p

Record details

Hidradenitis Suppurativa Market to Grow Positively at a Significant CAGR Key Companies- AbbVie, Novartis Pharmaceuticals, AbbVie, UCB Biopharma SPRL, Janssen Pharmaceuticals, Amgen, expected to boost the market

• Source: Herald Keeper (UK), July 31, 2023, 3pp

Record details

Breakthrough in Hidradenitis Suppurativa Therapy

• Authors : Duerr, Heidi Anne

• Source: Dermatology Times. May, 2023, Vol. 44 Issue 5, p30, 1 p.

Record details

New Data on Investigational Agent for HS Presented at Annual Meeting

• Authors : By:Heidi Anne Duerr, MPH

• Source: Dermatology Times (USA), March 18, 2023 News, 3pp

Record details

[Guidelines for the Management of Patients with Hidradenitis Suppurativa].

• Authors : Cabete J; Serviço de Dermatovenereologia. Hospital de Santo António dos Capuchos. Centro Hospitalar Universitário de Lisboa Central. Lisboa. Portugal.; Aparício Martins I

Subjects: Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/diagnosis ; Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/therapy; Humans

• Source: Acta medica portuguesa [Acta Med Port] 2023 Feb 01; Vol. 36 (2), pp. 133-139. Date of Electronic Publication: 2023 Feb 01.Publisher: Centro Editor Livreiro da Ordem dos Médicos Country of Publication: Portugal NLM ID: 7906803 Publication Model: Print-Electronic Cited Medium:

Record details

Recomendações na Abordagem do Doente com Hidradenite Supurativa.

• Authors : CABETE, Joana; APARÍCIO MARTINS, Inês

• Source: Acta Médica Portuguesa; Feb2023, Vol. 36 Issue 2, p133-141, 9p

Record details

Investigators at University of California San Francisco (UCSF) Report Findings in HIV/AIDS (Tnf-alpha Inhibition In the Setting of Undiagnosed Hiv Infection: a Call for Enhanced Screening Guidelines)

• Source: AIDS Weekly. March 28, 2022, 28

Record details